LOADING

Type to search

coronavirus anitbody drug COVID-19 Health Lifestyle Shanghai Junshi Biosciences

Shanghai Junshi Biosciences in human tests for coronavirus antibody drug

Share
Shanghai Junshi Biosciences in human tests for coronavirus antibody drug
[ad_1]

BEIJING: Shanghai Junshi Biosciences has began an early-stage research in China to check a possible antibody therapy towards the coronavirus in uninfected individuals, the corporate mentioned in a submitting on Sunday.

The experimental drug, JS016, can be anticipated to start human research within the United States within the second quarter of this yr, by collaboration with Eli Lilly and Co.

Junshi is amongst a number of biotech corporations and analysis institutes backed by world pharmaceutical giants to work on antibody-based therapies to assist these contaminated with the fast-spreading new coronavirus, which has killed almost 400,000 globally.

The firm hopes that its antibody, remoted from recovered sufferers’ blood and engineered by researchers, also can shield wholesome individuals with excessive an infection danger, similar to medical staff and the aged, from getting the virus, mentioned Feng Hui, chief working officer of Junshi.

But the product might be far more costly than a vaccine, a extra generally used preventive drugs for which a number of candidates are being examined, as Junshi’s antibody drug is predicted to comprise bigger quantities of pricey proteins in a single dose than a vaccine, Feng mentioned.


Twitter
and
Facebook

[ad_2]

Leave a Reply